MEOBF
Price
$0.96
Change
-$0.00 (-0.00%)
Updated
Jun 23 closing price
Capitalization
1.4B
55 days until earnings call
RLYB
Price
$0.33
Change
-$0.00 (-0.00%)
Updated
Jul 3, 10:57 AM (EDT)
Capitalization
13.44M
34 days until earnings call
Interact to see
Advertisement

MEOBF vs RLYB

Header iconMEOBF vs RLYB Comparison
Open Charts MEOBF vs RLYBBanner chart's image
Mesoblast
Price$0.96
Change-$0.00 (-0.00%)
Volume$1K
Capitalization1.4B
Rallybio
Price$0.33
Change-$0.00 (-0.00%)
Volume$5K
Capitalization13.44M
MEOBF vs RLYB Comparison Chart in %
Loading...
MEOBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLYB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MEOBF vs. RLYB commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MEOBF is a Buy and RLYB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2025
Stock price -- (MEOBF: $0.96 vs. RLYB: $0.33)
Brand notoriety: MEOBF and RLYB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MEOBF: 79% vs. RLYB: 0%
Market capitalization -- MEOBF: $1.4B vs. RLYB: $13.44M
MEOBF [@Biotechnology] is valued at $1.4B. RLYB’s [@Biotechnology] market capitalization is $13.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $307.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MEOBF’s FA Score shows that 0 FA rating(s) are green whileRLYB’s FA Score has 1 green FA rating(s).

  • MEOBF’s FA Score: 0 green, 5 red.
  • RLYB’s FA Score: 1 green, 4 red.
According to our system of comparison, RLYB is a better buy in the long-term than MEOBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MEOBF’s TA Score shows that 4 TA indicator(s) are bullish while RLYB’s TA Score has 6 bullish TA indicator(s).

  • MEOBF’s TA Score: 4 bullish, 3 bearish.
  • RLYB’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, RLYB is a better buy in the short-term than MEOBF.

Price Growth

MEOBF (@Biotechnology) experienced а 0.00% price change this week, while RLYB (@Biotechnology) price change was -5.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.20%. For the same industry, the average monthly price growth was +33.12%, and the average quarterly price growth was +1.51%.

Reported Earning Dates

MEOBF is expected to report earnings on Aug 27, 2025.

RLYB is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+1.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MEOBF($1.4B) has a higher market cap than RLYB($13.4M). MEOBF YTD gains are higher at: -56.136 vs. RLYB (-65.594). RLYB has higher annual earnings (EBITDA): -50.26M vs. MEOBF (-77.78M). RLYB has more cash in the bank: 54.5M vs. MEOBF (37.7M). RLYB has less debt than MEOBF: RLYB (116K) vs MEOBF (126M). MEOBF has higher revenues than RLYB: MEOBF (5.67M) vs RLYB (848K).
MEOBFRLYBMEOBF / RLYB
Capitalization1.4B13.4M10,440%
EBITDA-77.78M-50.26M155%
Gain YTD-56.136-65.59486%
P/E RatioN/AN/A-
Revenue5.67M848K669%
Total Cash37.7M54.5M69%
Total Debt126M116K108,621%
FUNDAMENTALS RATINGS
MEOBF: Fundamental Ratings
MEOBF
OUTLOOK RATING
1..100
37
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
61
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MEOBFRLYB
RSI
ODDS (%)
Bullish Trend 1 day ago
44%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
68%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
59%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
62%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
53%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
52%
Bullish Trend 1 day ago
87%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
Bearish Trend 1 day ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
50%
Bearish Trend 1 day ago
74%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MEOBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLYB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MMMSX21.640.30
+1.41%
Victory Integrity Small/Mid-Cap Value Mb
RYTCX7.980.06
+0.76%
Royce Small-Cap Total Return Consult
FTXNX43.960.33
+0.76%
FullerThaler Behavioral Sm-Cp Gr Inv
JRACX78.060.53
+0.68%
Janus Henderson Research C
SUFCX38.52N/A
N/A
NAA Mid Growth C

MEOBF and

Correlation & Price change

A.I.dvisor tells us that MEOBF and RLYB have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MEOBF and RLYB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEOBF
1D Price
Change %
MEOBF100%
N/A
RLYB - MEOBF
25%
Poorly correlated
N/A
ADIL - MEOBF
24%
Poorly correlated
+4.36%
MMIRF - MEOBF
10%
Poorly correlated
N/A
MLLCF - MEOBF
6%
Poorly correlated
N/A
IPHYF - MEOBF
5%
Poorly correlated
N/A
More

RLYB and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLYB has been loosely correlated with ATXS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if RLYB jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLYB
1D Price
Change %
RLYB100%
N/A
ATXS - RLYB
42%
Loosely correlated
+5.52%
PRME - RLYB
41%
Loosely correlated
+12.45%
GBIO - RLYB
38%
Loosely correlated
+5.59%
SLNO - RLYB
37%
Loosely correlated
+4.33%
LYEL - RLYB
36%
Loosely correlated
+0.05%
More